Efficacy and Safety of Dulaglutide in the Treatment of Type 2 Diabetes: A Comprehensive Review of the Dulaglutide Clinical Data Focusing on the AWARD Phase 3 Clinical Trial Program

Diabetes/Metabolism Research and Reviews - United States
doi 10.1002/dmrr.2810
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Efficacy and Safety of Dulaglutide Monotherapy Versus Metformin in Type 2 Diabetes in a Randomized Controlled Trial (AWARD-3)

Diabetes Care
Internal MedicineEndocrinologyAdvancedMetabolismSpecialized NursingDiabetes
2014English

Dulaglutide – New in the Treatment of Type 2 Diabetes

Effective Pharmacotherapy
2019English

Dulaglutide Slows Kidney Disease in Type 2 Diabetes

The Lancet
Medicine
2020English

A 1-Year Safety Study of Dulaglutide in Japanese Patients With Type 2 Diabetes on a Single Oral Hypoglycemic Agent: An Open-Label, Nonrandomized, Phase 3 Trial

Endocrine Journal
EndocrinologyMetabolismDiabetes
2015English

Dulaglutide: Third Once-Weekly GLP-1 Agonist for Type 2 Diabetes

Pharmacy Today
2014English

Dulaglutide Slows Kidney Disease in Type 2 Diabetes − Author's Reply

The Lancet
Medicine
2020English

The Cost-Effectiveness of Dulaglutide Versus Liraglutide in Patients With Type 2 Diabetes Mellitus in Taiwan

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2016English

The Diabetes Prevention Program. Design and Methods for a Clinical Trial in the Prevention of Type 2 Diabetes

Diabetes Care
Internal MedicineEndocrinologyAdvancedMetabolismSpecialized NursingDiabetes
1999English

Cardiovascular Protection in the Treatment of Type 2 Diabetes: A Review of Clinical Trial Results Across Drug Classes

American Journal of Cardiology
Cardiovascular MedicineCardiology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy